The post LINK Price Prediction: Targeting $20.50 by December 2025 Despite Short-Term Headwinds appeared on BitcoinEthereumNews.com. Alvin Lang Dec 06, 2025 06:48 LINK price prediction indicates potential 50% upside to $20.50 by December 2025, though immediate resistance at $14.50 poses near-term challenges for Chainlink bulls. Chainlink (LINK) finds itself at a critical juncture as December 2025 unfolds, with the token trading at $13.61 amid conflicting technical signals and varied analyst predictions. Our comprehensive LINK price prediction analysis suggests a cautiously optimistic outlook, with significant upside potential tempered by immediate technical challenges. LINK Price Prediction Summary • LINK short-term target (1 week): $14.50-$15.20 (+6.5% to +11.7%) • Chainlink medium-term forecast (1 month): $18.00-$22.00 range (+32% to +62%) • Key level to break for bullish continuation: $14.50 resistance • Critical support if bearish: $11.61 (immediate) / $10.70 (strong) Recent Chainlink Price Predictions from Analysts The latest wave of analyst predictions reveals a fascinating divergence in LINK price prediction methodologies. CoinDCX leads the bullish camp with an aggressive $20.50 target by December 2025, citing improving market structure and steady oracle integration growth. This Chainlink forecast aligns with the fundamental thesis that LINK’s utility continues expanding across DeFi protocols. Blockchain.News pushes even further with a $25.40 prediction within 30 days, supported by MACD histogram turning positive. However, more conservative voices like Changelly predict a near-term decline to $11.98, suggesting the current technical setup favors consolidation before any significant breakout. The most aggressive short-term LINK price prediction comes from DigitalCoinPrice, targeting $29.66 with a projected 117.30% increase by December’s end. While this represents the bulls’ best-case scenario, it requires breaking multiple resistance levels and sustained buying pressure. LINK Technical Analysis: Setting Up for Potential Breakout Current Chainlink technical analysis reveals a token caught between competing forces. With LINK trading at $13.61, the price sits just above the 20-day SMA ($13.20) but remains well… The post LINK Price Prediction: Targeting $20.50 by December 2025 Despite Short-Term Headwinds appeared on BitcoinEthereumNews.com. Alvin Lang Dec 06, 2025 06:48 LINK price prediction indicates potential 50% upside to $20.50 by December 2025, though immediate resistance at $14.50 poses near-term challenges for Chainlink bulls. Chainlink (LINK) finds itself at a critical juncture as December 2025 unfolds, with the token trading at $13.61 amid conflicting technical signals and varied analyst predictions. Our comprehensive LINK price prediction analysis suggests a cautiously optimistic outlook, with significant upside potential tempered by immediate technical challenges. LINK Price Prediction Summary • LINK short-term target (1 week): $14.50-$15.20 (+6.5% to +11.7%) • Chainlink medium-term forecast (1 month): $18.00-$22.00 range (+32% to +62%) • Key level to break for bullish continuation: $14.50 resistance • Critical support if bearish: $11.61 (immediate) / $10.70 (strong) Recent Chainlink Price Predictions from Analysts The latest wave of analyst predictions reveals a fascinating divergence in LINK price prediction methodologies. CoinDCX leads the bullish camp with an aggressive $20.50 target by December 2025, citing improving market structure and steady oracle integration growth. This Chainlink forecast aligns with the fundamental thesis that LINK’s utility continues expanding across DeFi protocols. Blockchain.News pushes even further with a $25.40 prediction within 30 days, supported by MACD histogram turning positive. However, more conservative voices like Changelly predict a near-term decline to $11.98, suggesting the current technical setup favors consolidation before any significant breakout. The most aggressive short-term LINK price prediction comes from DigitalCoinPrice, targeting $29.66 with a projected 117.30% increase by December’s end. While this represents the bulls’ best-case scenario, it requires breaking multiple resistance levels and sustained buying pressure. LINK Technical Analysis: Setting Up for Potential Breakout Current Chainlink technical analysis reveals a token caught between competing forces. With LINK trading at $13.61, the price sits just above the 20-day SMA ($13.20) but remains well…

LINK Price Prediction: Targeting $20.50 by December 2025 Despite Short-Term Headwinds



Alvin Lang
Dec 06, 2025 06:48

LINK price prediction indicates potential 50% upside to $20.50 by December 2025, though immediate resistance at $14.50 poses near-term challenges for Chainlink bulls.

Chainlink (LINK) finds itself at a critical juncture as December 2025 unfolds, with the token trading at $13.61 amid conflicting technical signals and varied analyst predictions. Our comprehensive LINK price prediction analysis suggests a cautiously optimistic outlook, with significant upside potential tempered by immediate technical challenges.

LINK short-term target (1 week): $14.50-$15.20 (+6.5% to +11.7%)
Chainlink medium-term forecast (1 month): $18.00-$22.00 range (+32% to +62%)
Key level to break for bullish continuation: $14.50 resistance
Critical support if bearish: $11.61 (immediate) / $10.70 (strong)

The latest wave of analyst predictions reveals a fascinating divergence in LINK price prediction methodologies. CoinDCX leads the bullish camp with an aggressive $20.50 target by December 2025, citing improving market structure and steady oracle integration growth. This Chainlink forecast aligns with the fundamental thesis that LINK’s utility continues expanding across DeFi protocols.

Blockchain.News pushes even further with a $25.40 prediction within 30 days, supported by MACD histogram turning positive. However, more conservative voices like Changelly predict a near-term decline to $11.98, suggesting the current technical setup favors consolidation before any significant breakout.

The most aggressive short-term LINK price prediction comes from DigitalCoinPrice, targeting $29.66 with a projected 117.30% increase by December’s end. While this represents the bulls’ best-case scenario, it requires breaking multiple resistance levels and sustained buying pressure.

Current Chainlink technical analysis reveals a token caught between competing forces. With LINK trading at $13.61, the price sits just above the 20-day SMA ($13.20) but remains well below the 50-day SMA ($15.13), indicating medium-term bearish pressure.

The MACD histogram’s positive reading of 0.2625 provides the strongest bullish signal in our analysis, suggesting momentum is shifting despite the overall negative MACD value of -0.3937. This divergence often precedes significant price moves, supporting our medium-term LINK price target of $20.50.

Volume analysis shows healthy participation at $46.2 million in 24-hour trading, sufficient to support a breakout above the critical $14.50 resistance level. The Bollinger Bands position (0.6596) indicates LINK is trending toward the upper band, though not yet overbought.

Our primary bullish LINK price prediction targets $20.50 by December 2025, representing a 50.7% gain from current levels. This Chainlink forecast requires several technical developments:

Breaking above $14.50 resistance would trigger the first leg toward $16.22, matching CoinMarketCap AI’s breakout target. From there, sustained momentum could push LINK toward the $19.19 strong resistance level, with final targets around $20.50-$22.00.

The 52-week high at $26.79 remains the ultimate bull target, though achieving this level would require exceptional fundamental catalysts beyond normal technical progression.

Failure to break $14.50 resistance could trigger our bearish LINK price prediction scenario. The immediate support at $11.61 represents the first critical test, aligning with Changelly’s $11.98 target.

A break below this level would expose the $10.70 support, matching CoinMarketCap AI’s downside target. This scenario would invalidate our bullish Chainlink forecast and suggest further consolidation or decline toward the 52-week low of $10.93.

Should You Buy LINK Now? Entry Strategy

Based on our LINK price prediction analysis, we recommend a layered entry approach for those asking “buy or sell LINK”:

Aggressive Entry: Current levels around $13.61 offer reasonable risk-reward for those believing in the $20.50 target, with stop-loss at $11.50.

Conservative Entry: Wait for a breakout above $14.50 with volume confirmation before initiating positions, targeting the same $20.50 LINK price target.

Risk Management: Position sizes should not exceed 2-3% of portfolio value given the mixed technical signals and varied analyst predictions.

Our comprehensive analysis supports a medium confidence LINK price prediction of $20.50 by December 2025, representing potential 50% upside. However, the immediate challenge at $14.50 resistance cannot be ignored.

The Chainlink forecast depends heavily on breaking this critical level with volume confirmation. Traders should monitor the MACD histogram for continued bullish divergence and watch for sustained breaks above the 50-day SMA at $15.13.

Our LINK price target timeline extends through December 2025, though early signals of validation or invalidation should emerge within the next 7-10 trading days as LINK either breaks $14.50 or retreats toward support levels.

Key Indicators to Watch: MACD histogram sustainability, volume on any $14.50 breakout attempt, and RSI movement above 55 for momentum confirmation.

Image source: Shutterstock

Source: https://blockchain.news/news/20251206-price-prediction-link-targeting-2050-by-december-2025-despite

Market Opportunity
Chainlink Logo
Chainlink Price(LINK)
$8.56
$8.56$8.56
-2.28%
USD
Chainlink (LINK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26